Teva Pharmaceutical Industries Ltd (TEVA) income statement
TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
$41.31−0.19 (-0.46%)
Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –
Teva Pharmaceutical Industries Ltd financial ratios
See a number that looks wrong?